Skip to content
← Full study record

NCT03126630 · MORE INFO

Limitations, agreements, and source contact

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma · Source last updated 2026-04-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
mansfield.aaron@mayo.edu
organization
Mayo Clinic
phone
(507) 284-2511
title
Dr. Aaron Mansfield
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
mansfield.aaron@mayo.edu
organization
Mayo Clinic
phone
(507) 284-2511
title
Dr. Aaron Mansfield

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice